Taiwan Liposome Company, Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2021 | Q2 2021 | -$1.79 | $160.18 M | |||
| 03/30/2021 | Q1 2021 | -$4.78 | $37.62 M | |||
| 12/30/2020 | Q4 2020 | -$6.96 | $12.08 M | |||
| 09/29/2020 | Q3 2020 | -$5.56 | $66.10 M | |||
| 06/29/2020 | Q2 2020 | -$6.56 | $11.78 M | |||
| 03/30/2020 | Q1 2020 | -$5.80 | $11.97 M | |||
| 12/30/2019 | Q4 2019 | -$8.60 | $11.95 M | |||
| 09/29/2019 | Q3 2019 | -$5.60 | $18.84 M | |||
| 06/29/2019 | Q2 2019 | -$7.58 | $20.59 M | |||
| 03/30/2019 | Q1 2019 | -$3.52 | $157.77 M | |||
| 12/30/2018 | Q4 2018 | -$10.94 | $17.38 M | |||
| 09/29/2018 | Q3 2018 | -$7.04 | $15.28 M | |||
| 06/29/2018 | Q2 2018 | -$8.36 | $15.57 M | |||
| 03/30/2018 | Q1 2018 | -$5.98 | $14.09 M | |||
| 12/30/2017 | Q4 2017 | -$9.40 | $12.40 M | |||
| 09/29/2017 | Q3 2017 | -$8.06 | $13.37 M | |||
| 06/29/2017 | Q2 2017 | -$8.18 | $12.01 M | |||
| 03/30/2017 | Q1 2017 | -$5.74 | $11.86 M | |||
| 12/30/2016 | Q4 2016 | -$9.61 | $12.64 M | |||
| 09/29/2016 | Q3 2016 | -$8.48 | $9.82 M |
Taiwan Liposome Company, Ltd. Earnings: Frequently Asked Questions
-
Did Taiwan Liposome Company, Ltd. beat their earnings estimates last quarter?
In the previous quarter, Taiwan Liposome Company, Ltd. (:TLC) reported $-0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.13 by $0.09.
-
How can I listen to Taiwan Liposome Company, Ltd.'s earnings conference call?
The conference call for Taiwan Liposome Company, Ltd.'s latest earnings report can be listened to online.
-
How can I read Taiwan Liposome Company, Ltd.'s conference call transcript?
The conference call transcript for Taiwan Liposome Company, Ltd.'s latest earnings report can be read online.
-
How much revenue does Taiwan Liposome Company, Ltd. generate each year?
Taiwan Liposome Company, Ltd. (:TLC) has a recorded annual revenue of $101.93 M.
-
How much profit does Taiwan Liposome Company, Ltd. generate each year?
Taiwan Liposome Company, Ltd. (:TLC) has a recorded net income of $101.93 M. Taiwan Liposome Company, Ltd. has generated $-24.89 earnings per share over the last four quarters.
-
What is Taiwan Liposome Company, Ltd.'s price-to-earnings ratio?
Taiwan Liposome Company, Ltd. (:TLC) has a price-to-earnings ratio of -9.01 and price/earnings-to-growth ratio is 8.88.
